Northwest Biotherapeutics (NWBO) Other Non Operating Income (2010 - 2026)

Northwest Biotherapeutics' Other Non Operating Income history runs 17 years deep, the most recent figure standing at -$1.3 million for Q1 2026.

• In Q1 2026, Other Non Operating Income rose 81.54% year-over-year to -$1.3 million; the TTM figure through Mar 2026 stood at $1.4 million (up 110.66% YoY), while the FY2025 annual figure was -$6.8 million, down 1976.92% from the prior year.
• Other Non Operating Income for Q1 2026 stood at -$1.3 million, down from $8.3 million in the prior quarter.
• The five-year high for Other Non Operating Income was $8.3 million in Q4 2025, with the low at -$19.0 million in Q4 2022.
• The 5-year median for Other Non Operating Income is -$1.7 million (2024), against an average of -$2.7 million.
• Peak annual rise in Other Non Operating Income reached 593.64% in 2025, while the deepest fall reached 9935.56% in 2025.
• Northwest Biotherapeutics' Other Non Operating Income stood at -$19.0 million in 2022, then surged by 51.11% to -$9.3 million in 2023, then jumped by 81.86% to -$1.7 million in 2024, then surged by 593.64% to $8.3 million in 2025, then tumbled by 116.18% to -$1.3 million in 2026.
• Business Quant data shows NWBO's Other Non Operating Income at -$1.3 million in Q1 2026, $8.3 million in Q4 2025, and -$1.0 million in Q3 2025.